Y Intercept Hong Kong Ltd Takes $546,000 Position in SPDR S&P Biotech ETF $XBI

Y Intercept Hong Kong Ltd acquired a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm acquired 6,586 shares of the exchange traded fund’s stock, valued at approximately $546,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Goldman Sachs Group Inc. increased its stake in SPDR S&P Biotech ETF by 33.0% in the 1st quarter. Goldman Sachs Group Inc. now owns 13,524,858 shares of the exchange traded fund’s stock valued at $1,096,866,000 after buying an additional 3,353,029 shares during the last quarter. JPMorgan Chase & Co. boosted its position in SPDR S&P Biotech ETF by 625.1% in the first quarter. JPMorgan Chase & Co. now owns 10,369,706 shares of the exchange traded fund’s stock worth $840,983,000 after purchasing an additional 12,344,558 shares during the last quarter. Bessemer Group Inc. increased its position in SPDR S&P Biotech ETF by 4.4% in the second quarter. Bessemer Group Inc. now owns 1,494,666 shares of the exchange traded fund’s stock worth $123,951,000 after buying an additional 62,600 shares during the last quarter. Migdal Insurance & Financial Holdings Ltd. bought a new stake in shares of SPDR S&P Biotech ETF in the first quarter valued at $85,155,000. Finally, Hsbc Holdings PLC lifted its position in shares of SPDR S&P Biotech ETF by 2.7% during the 1st quarter. Hsbc Holdings PLC now owns 819,267 shares of the exchange traded fund’s stock valued at $65,379,000 after buying an additional 21,804 shares during the last quarter.

SPDR S&P Biotech ETF Stock Performance

Shares of XBI opened at $109.29 on Friday. SPDR S&P Biotech ETF has a fifty-two week low of $66.66 and a fifty-two week high of $113.21. The business has a 50-day moving average of $101.83 and a 200 day moving average of $90.10. The firm has a market cap of $6.63 billion, a P/E ratio of 11.47 and a beta of 0.93.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.